Researcher.Life Logo

Annals of Hepatology : Impact Factor & More

eISSN: 2659-5982pISSN: 1665-2681
JournalOpen Access

Key Metrics

CiteScore
4.7
Impact Factor
< 5
SJR
Q3Hepatology
SNIP
0.88
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Annals of Hepatology

Annals of Hepatology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Elsevier
Language English
Article Processing ChargesUSD 1500
Publication Time36
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorFundación Clínica Médica Sur, A.C.
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 36
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Annals of Hepatology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Annals of Hepatology

Liver transplant outcomes of deceased donor types following normothermic machine perfusion: A meta-analysis.
  • 1 Jul 2026
  • Annals of hepatology
Alarming increase of acute liver failure during Sudan's conflict: a call for urgent global hepatology response.
  • 1 Jul 2026
  • Annals of hepatology
Situational panorama of chronic liver diseases: A single-center experience at a university hospital in northeast Mexico (1995-2019).
  • 1 Jul 2026
  • Annals of hepatology
Metabolic dysfunction-associated steatotic liver disease: No alcohol.
  • 1 Feb 2026
  • Annals of hepatology
Re-evaluating serum IL-6 as a prognostic biomarker in HCC immunotherapy with atezolizumab plus bevacizumab: the critical role of baseline liver function and disease etiology.
  • 1 Feb 2026
  • Annals of hepatology
Reply to: Comment on "pancreatic involvement and its prognostic impact in acute-on chronic liver failure".
  • 1 Feb 2026
  • Annals of hepatology
Liver transplant outcomes of deceased donor types following normothermic machine perfusion: A meta-analysis.
  • 1 Jul 2026
  • Annals of hepatology
Alarming increase of acute liver failure during Sudan's conflict: a call for urgent global hepatology response.
  • 1 Jul 2026
  • Annals of hepatology
Situational panorama of chronic liver diseases: A single-center experience at a university hospital in northeast Mexico (1995-2019).
  • 1 Jul 2026
  • Annals of hepatology
Metabolic dysfunction-associated steatotic liver disease: No alcohol.
  • 1 Feb 2026
  • Annals of hepatology
Re-evaluating serum IL-6 as a prognostic biomarker in HCC immunotherapy with atezolizumab plus bevacizumab: the critical role of baseline liver function and disease etiology.
  • 1 Feb 2026
  • Annals of hepatology
Reply to: Comment on "pancreatic involvement and its prognostic impact in acute-on chronic liver failure".
  • 1 Feb 2026
  • Annals of hepatology

FAQs on Annals of Hepatology